Five New Jersey pharmacies pay nearly $2 million to settle false claims over undispensed medications

NEWARK, N.J. — Five pharmacies operating in Jersey City, Bayonne, and Elizabeth have agreed to pay a total of $1,935,000 to resolve allegations that they submitted false claims to federal health care programs for medications that were never actually dispensed,…

U.S. Attorney’s Office Announces Agreement to Ensure Access to Medications for Opioid Use Disorder at Big Sandy Regional Detention Center

LEXINGTON, Ky. – United States Attorney Carlton S. Shier, IV, announced Monday that the federal government has reached an agreement with the Big Sandy Regional Jail Authority, which operates the Big Sandy Regional Detention Center (BSRDC), to ensure that people…

medications

Five New Jersey pharmacies pay nearly $2 million to settle false claims over undispensed medications

U.S. Attorney’s Office Announces Agreement to Ensure Access to Medications for Opioid Use Disorder at Big Sandy Regional Detention Center

Justice Department Secures Agreement from Pennsylvania Jail to Provide Medications for Opioid Use Disorder

Registered Nurse Indicted for Illegally Obtaining Prescription Opioids from Baxter Hospice Clinic

Former Roswell Park Nurse Sentenced For Tampering With Medications Intended For Patients

U.S. Attorney’s Office Announces Agreement to Ensure Access to Medications for Opioid Use Disorder at Fayette County Detention Center

Former Nurse Sentenced to 18 Months in Federal Prison for Tampering with Morphine Medications at Moses Lake Clinic

Nearly 24,000 Pounds of Unused Medications Collected in Pacific Northwest During DEA Drug Take Back Day

Lyndonville Woman Sentenced for Selling Misbranded Pet Medications

DOJ and Skagit County health clinic resolve False Claims Act investigation over the use of imported birth control medications

U.S. Attorney Rollins Announces Correctional Facilities Statewide to Maintain All Medications for Opioid Use Disorder

Federal Civil and Criminal Investigations Result in Six Convictions and Recovery of Over $8.7 Million in Connection with Compounded Medications Formulated by DelCo Pharmacy

U.S. Attorney’s Office Settles Disability Discrimination Allegations with the Massachusetts Trial Court Concerning Access to Medications for Opioid Use Disorder

New Data on Cost Impact of Treating Opioid-Induced Constipation (OIC) with FDA-Approved Medications, Including Salix’s RELISTOR® Subcutaneous Injection (Methylnaltrexone Bromide), in The Emergency Department Is Published in Advances In Therapy

Pharmacist Charged in a Scheme to Bill Insurance for Medications Not Dispensed

Atlanta pharmacy to pay $4.6 million to settle False Claims Act allegations regarding compound medications

Facebook